702
B. S. Olson, D. Trauner
CLUSTER
What is the relationship between smenochromene D and
likonide B? The possibility had to be taken into account
that likonide B ([a]D +27) is an atropisomer of smeno-
chromene D ([a]D –68.5). Careful comparison of the
NMR spectra of our synthetic material in various solvents
with the reported spectra of smenochromene D and
likonide B,1,2 respectively, as well as a detailed NOE
study, however, showed that the two compounds are iden-
tical with respect to their relative stereochemistry. Smeno-
chromene D and likonide B, therefore, appear to be
enantiomers, or at least enantioenriched in an opposite
sense, explaining the wide discrepancy in the absolute nu-
merical value of their reported optical rotation.
References
(1) Clardy, J.; Faulkner, D. J.; Venkateswarlu, Y.; Rios Steiner,
J. L.; Corcoran, E. J. Org. Chem. 1991, 56, 6271.
(2) Kashman, Y.; Rudi, A.; Benayahu, Y. Org. Lett. 2004, 6,
4013.
(3) For a comprehensive review on the chemistry of ortho-
quinone methides, see: Van de Water, R. W.; Pettus, T. R. R.
Tetrahedron 2002, 58, 5367.
(4) Umbreit, M. A.; Sharpless, K. B. J. Am. Chem. Soc. 1977,
99, 5526.
(5) Banwell, M. G.; Flynn, B. L.; Stewart, S. G. J. Org. Chem.
1998, 63, 9139.
(6) Parikh, J. R.; von Doering, W. E. J. Am. Chem. Soc. 1967,
89, 5505.
(7) (a) Snieckus, V.; Chauder, B. A.; Lopes, C. C.; Lopes, R. S.
C.; da Silva, A. J. M. Synthesis 1998, 279. (b) Murphy, W.
S.; Tuladhar, S. M.; Duffy, B. J. Chem. Soc., Perkin Trans.
1 1992, 605. (c) Bissada, S.; Lau, C. K.; Bernstein, M. A.;
Dufresne, C. Can. J. Chem. 1994, 72, 1866.
In summary, we have achieved a concise, five-step syn-
thesis of racemic smenochromene D (likonide B), starting
from commercially available farnesyl acetate. Synthetic
studies directed at other members of the smenochromene
family are well underway in our laboratories and asym-
metric versions involving chiral Lewis acids or arylboron-
ic acids will be attempted. The conversion of likonide B
into likonide A via [3,3] sigmatropic rearrangement, as
well as the conversion of the hetero-macrocyclic into the
carba-macrocyclic smenochromene series is under active
investigation as well and will be reported in due course.
(8) Experimental Procedure.
To a solution of 10 (20.0 mg, 0.0558 mmol) in toluene (4
mL) was added phenylboronic acid (14.0 mg, 0.0837 mmol)
and HOAc 0.400 mL. The reaction mixture was then fitted
with a Dean Stark apparatus and heated at reflux for 3 h. The
mixture was cooled to r.t., diluted with CH2Cl2, washed with
H2O, sat. NaHCO3, and brine, dried over MgSO4, and
concentrated in vacuo. The product was purified by column
chromatography (10% EtOAc in hexane) to afford 4.9 mg
(26%) of smenochromene D as a clear oil. Rf = 0.26 (10%
EtOAc in hexane, CAM). IR: 3394, 2921, 2852, 1616, 1505
cm–1. 1H NMR: (500 MHz): d = 6.52 (s, 1 H), 6.31 (d,
J = 12.8 Hz, 1 H), 6.29 (s, 1 H), 5.31 (d, J = 12.8 Hz, 1 H),
4.93 (t, J = 7.2 Hz, 1 H), 4.82 (t, J = 8, 1 H), 4.52 (d, J = 15.2
Hz, 1 H), 4.14 (d, J = 15.2 Hz, 1 H), 3.76 (s, 3 H), 2.09 (m,
4 H), 1.77 (m, 2 H), 1.69 (s, 3 H), 1.58 (m, 2 H), 1.47, (s, 3
H), 1.36 (s, 3 H). 13C NMR (500 MHz): d = 153.4, 150.3,
139.3, 132.0, 131.8, 129.8, 126.6, 125.8, 123.5, 119.1,
113.3, 99.9, 80.3, 79.0, 55.6, 41.4, 38.9, 30.2, 24.6, 23.1,
14.4, 14.1. HRMS: m/z calcd for C22H2803 [M+]: 340.2038;
found: 340.2033.
Acknowledgment
Financial support by Eli Lilly, Glaxo-Smith-Kline, Merck & Co.,
and Astra Zeneca is gratefully acknowledged.
(9) Nagata, W.; Okada, K. Synthesis 1979, 365.
Synlett 2005, No. 4, 700–702 © Thieme Stuttgart · New York